Posted in | News | Molybdenum

General Moly Announces Hanlong's Receipt of Second Chinese Governmental Approval

General Moly, the U.S. molybdenum producer, announced that it had been told by Sichuan Hanlong Group (Hanlong) that the Chinese company has received formal approval from the Chinese National Development and Reform Commission (NDRC) to invest in General Moly.

The Mt. Hope project is one of the world's largest and highest grade undeveloped molybdenum projects. The project is owned 80% by General Moly and 20% by POSCO through a joint venture. Image Credit: General Moly

This is a component of an overall structure to fully finance General Moly's 80%-owned share of the Mt. Hope project. The funds will be used by the company to resume engineering and procurement as well as the publication of the Draft Environmental Impact Statement or DEIS of the project.

Bruce D. Hansen, Chief Executive Officer of General Moly, said that the NDRC approval represented another key milestone reached in the overall finance and development plan of the world class Mt Hope molybdenum project.

The completetion and publication of the DEIS will see General Molly close the initial 12.5% fully diluted share sale to Hanlong for U.S.$40 million. It would also begin the public review period for the project which is the last stage of federal permitting for Mt Hope.

Hanlon would pay an additional U.S.$ 40 million to increase its interest in General Molly to 25% after receipt of its Record of Decision or ROD. The ROD is anticipated in mid 2011 by General Molly.

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 18). General Moly Announces Hanlong's Receipt of Second Chinese Governmental Approval. AZoMining. Retrieved on November 21, 2024 from https://www.azomining.com/News.aspx?newsID=552.

  • MLA

    Scanlon, Joel. "General Moly Announces Hanlong's Receipt of Second Chinese Governmental Approval". AZoMining. 21 November 2024. <https://www.azomining.com/News.aspx?newsID=552>.

  • Chicago

    Scanlon, Joel. "General Moly Announces Hanlong's Receipt of Second Chinese Governmental Approval". AZoMining. https://www.azomining.com/News.aspx?newsID=552. (accessed November 21, 2024).

  • Harvard

    Scanlon, Joel. 2019. General Moly Announces Hanlong's Receipt of Second Chinese Governmental Approval. AZoMining, viewed 21 November 2024, https://www.azomining.com/News.aspx?newsID=552.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.